Latest IMPH Community News

Major U.S. trial closes showing no benefit for hydroxychloroquine in COVID-19

June 16, 2020
https://news.vumc.org/2020/06/21/major-u-s-trial-closes-showing-no-benefit-for-hydroxychloroquine-in-covid-19/
The Outcomes Related to COVID-19 Treated with Hydroxychloroquine among In-patients with Symptomatic Disease (ORCHID) trial stopped enrolling new patients based on the fourth scheduled interim analysis showing no evidence of benefit or harm.

Study launched to test hydroxychloroquine as treatment for COVID-19

April 8, 2020
https://news.vumc.org/2020/04/08/nhlbi-launches-study-of-drug-to-treat-covid-19/
Faced with a global pandemic of a virus previously unknown to humans, Vanderbilt University Medical Center (VUMC) is leading a clinical trial to understand if hydroxychloroquine, a well-known drug used for malaria and rheumatologic conditions, is safe and effective in treating hospitalized adults with COVID-19.
RSS: